EUVIMEDEUVIMED entdecken
Übersichtsarbeit

AA amyloidosis associated with cancers

Joyita Bharati, Oscar B Lahoud, Kenar D Jhaveri iD, Hassan Izzedine iD

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfac217 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Joyita Bharati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Amyloidosis, Immunoglobulin Light-chain Amyloidosis, Kidney Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Astex Pharmaceuticals, GlaxoSmithKline, George Clinicals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic AA amyloidosis is associated with systemic inflammatory processes such as autoimmune disorders or chronic infections. In addition, AA amyloidosis can develop in a localized or systemic form in patients with malignant neoplastic disorders, and usually involves kidneys impacting renal function. Among solid tumors, renal cell carcinoma (RCC) appears to be responsible for one-quarter to half of all cancers associated with amyloidosis. Among other solid cancers, various clinical presentations and pathological types of lung cancer and basal cell carcinoma skin were reported with AA amyloidosis more often than isolated case reports on other cancers with AA amyloidosis. Symptoms from kidney involvement rather than from the tumor per se were the presenting manifestations in cases of RCC associated with AA amyloidosis. Among hematological malignancies, clonal B cell/plasma cell dyscrasias such as monoclonal gammopathy and lymphoma were noted to be associated with AA amyloidosis. In addition, AA amyloidosis was reported in a substantial number of cases treated with immune checkpoint inhibitors such as pembrolizumab and nivolumab. The mechanism of association of cancer and AA amyloidosis seems to be mediated by the immune response exacerbated from the tumor and its microenvironment or immune therapy. The mainstay of treatment consists of therapy directed against the underlying malignancy or careful withdrawal of the offending agent. This review will discuss this rare but highly morbid clinical condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellAmyloidosisImmunoglobulin Light-chain AmyloidosisKidney NeoplasmsHumansKidneyTumor MicroenvironmentSerum Amyloid A Protein

Stichwörter der Autor:innen

AA amyloidosisonconephrologyparaneoplastic syndromerenal cell carcinomasolid cancer

Substanzen

Serum Amyloid A Protein

Autor:innen und Institutionen

  • Department of Nephrology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Glomerular Center at Northwell Health, Division of Kidney Diseases and Hypertension, Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.
  • Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Nephrology, Peupliers Private Hospital, Ramsay Générale de Santé, Paris, France.

ORCID-Profile: Kenar D Jhaveri, Hassan Izzedine

Förderung

  • Astex Pharmaceuticals
  • GlaxoSmithKline
  • George Clinicals
  • International Society of Nephrology
  • American Society of Nephrology

Zitieren

APA

Bharati, J., Lahoud, O. B., Jhaveri, K. D., & Izzedine, H. (2023). AA amyloidosis associated with cancers. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac217

Vancouver

Bharati J, Lahoud OB, Jhaveri KD, Izzedine H. AA amyloidosis associated with cancers. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac217

BibTeX
@article{Bharati2023,
  author = {Bharati, Joyita and Lahoud, Oscar B and Jhaveri, Kenar D and Izzedine, Hassan},
  title = {AA amyloidosis associated with cancers},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfac217}
}
Kostenlos starten →